Contributing Authors |
|
xvii | |
Glossary |
|
xix | |
Introduction |
|
xxv | |
|
Acknowledgments |
|
xxx | |
References |
|
xxx | |
|
PART 1 THE PHYSICS OF MEDICAL ULTRASOUND |
|
|
1 | (88) |
|
1 Ultrasonic Fields: Structure and Prediction |
|
|
3 | (20) |
|
|
|
1.1 Circular plane sources |
|
|
4 | (6) |
|
1.1.1 Pressure variation on the axis |
|
|
6 | (3) |
|
1.1.2 Pressure variation off the axis |
|
|
9 | (1) |
|
|
10 | (3) |
|
|
13 | (2) |
|
1.4 Source amplitude weighting |
|
|
15 | (2) |
|
|
17 | (4) |
|
1.6 Conclusion 20 References |
|
|
21 | (2) |
|
2 Nonlinear Effects in Ultrasound Propagation |
|
|
23 | (16) |
|
|
2.1 Nonlinear propagation in medical ultrasound |
|
|
24 | (3) |
|
2.2 Consequences of nonlinear propagation |
|
|
27 | (12) |
|
2.2.1 Experimental measurements |
|
|
27 | (4) |
|
2.2.2 Theoretical predictions |
|
|
31 | (5) |
|
2.2.3 Clinical systems 34 References |
|
|
36 | (3) |
|
3 Radiation Pressure and Acoustic Streaming |
|
|
39 | (18) |
|
|
|
39 | (1) |
|
3.2 Langevin radiation pressure, PLan |
|
|
40 | (3) |
|
3.3 Radiation stress tensor |
|
|
43 | (1) |
|
3.3.1 The excess pressure |
|
|
43 | (1) |
|
3.4 Rayleigh radiation pressure, PRay |
|
|
44 | (2) |
|
|
46 | (6) |
|
3.5.1 Methods of measuring acoustic streaming |
|
|
50 | (2) |
|
3.6 Observations in vivo of radiation pressure effects |
|
|
52 | (1) |
|
|
52 | (1) |
|
3.6.2 Observed biological effects apparently related to radiation pressure |
|
|
52 | (1) |
|
|
53 | (4) |
|
|
54 | (3) |
|
4 Ultrasonic Properties of Tissues |
|
|
57 | (32) |
|
|
|
57 | (7) |
|
4.1.1 Attenuation, absorption, scattering and reflection |
|
|
57 | (4) |
|
|
61 | (1) |
|
|
61 | (1) |
|
4.1.4 Transducer diffraction field |
|
|
61 | (1) |
|
4.1.5 Pulse-echo imaging, speckle and echo texture |
|
|
62 | (2) |
|
4.1.6 Receiver phase sensitivity |
|
|
64 | (1) |
|
|
64 | (9) |
|
4.2.1 Measurement of the absorption coefficient |
|
|
64 | (1) |
|
4.2.2 Measurement of the attenuation coefficient |
|
|
65 | (3) |
|
4.2.3 Measurement of sound speed |
|
|
68 | (2) |
|
4.2.4 Measurement of scattering |
|
|
70 | (2) |
|
4.2.5 Measurement of nonlinearity |
|
|
72 | (1) |
|
4.3 Ultrasonic properties of tissues |
|
|
73 | (16) |
|
4.3.1 Absorption and attenuation |
|
|
73 | (3) |
|
|
76 | (2) |
|
|
78 | (5) |
|
|
83 | (1) |
|
|
83 | (6) |
|
PART 2 TECHNOLOGY AND MEASUREMENT IN DIAGNOSTIC IMAGING |
|
|
89 | (60) |
|
5 Transducer Arrays for Medical Ultrasound Imaging |
|
|
91 | (38) |
|
|
5.1 Piezoelectric transducer elements |
|
|
91 | (11) |
|
5.1.1 A basic transducer model |
|
|
91 | (2) |
|
5.1.2 Transducer elements as acoustic resonators |
|
|
93 | (2) |
|
5.1.3 Transducer array structures |
|
|
95 | (1) |
|
|
96 | (3) |
|
|
99 | (3) |
|
|
102 | (1) |
|
|
103 | (5) |
|
|
108 | (1) |
|
|
109 | (4) |
|
References 109 CURRENT DOPPLER TECHNOLOGY AND TECHNIQUES |
|
|
113 | (1) |
|
|
|
113 | (1) |
|
6.2 The origin of the Doppler signal |
|
|
114 | (2) |
|
6.3 The narrow frequency band technique |
|
|
116 | (4) |
|
6.3.1 The continuous wave Doppler technique |
|
|
116 | (2) |
|
6.3.2 The pulsed Doppler technique |
|
|
118 | (2) |
|
6.4 Frequency spectrum analysis |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (5) |
|
|
121 | (2) |
|
6.6.2 Autocorrelation detection |
|
|
123 | (1) |
|
6.6.3 Other Doppler frequency estimators |
|
|
123 | (1) |
|
6.6.4 Time-domain processing |
|
|
124 | (1) |
|
6.6.5 Colour coding schemes |
|
|
125 | (1) |
|
6.6.6 Three-dimensional display |
|
|
126 | (1) |
|
6.7 Contrast agents and second harmonic imaging |
|
|
126 | (3) |
|
|
127 | (2) |
|
7 The Purpose and Techniques of Acoustic Output Measurement |
|
|
129 | (20) |
|
|
7.1 Why measure acoustic outputs? |
|
|
129 | (1) |
|
7.2 Ultrasound damage mechanisms and their biological significance |
|
|
129 | (4) |
|
|
130 | (1) |
|
|
131 | (2) |
|
7.3 Trends in acoustic outputs |
|
|
133 | (1) |
|
7.4 Regulations and standards |
|
|
134 | (3) |
|
7.4.1 FDA 510(k) regulations |
|
|
135 | (1) |
|
7.4.2 AIUM/NEMA Output Display Standard |
|
|
135 | (1) |
|
|
136 | (1) |
|
7.5 Is there a need for independent measurements? |
|
|
137 | (1) |
|
7.6 Which output parameters should be measured? |
|
|
137 | (1) |
|
7.7 The Newcastle portable system for acoustic output measurements at hospital sites |
|
|
138 | (4) |
|
7.7.1 The hydrophone and pre-amplifier |
|
|
138 | (2) |
|
7.7.2 Variable attenuator, power amplifier and power meter |
|
|
140 | (1) |
|
|
141 | (1) |
|
7.7.4 Oscilloscope camera, PC and digitisation tablet |
|
|
141 | (1) |
|
7.7.5 The measurement tank |
|
|
141 | (1) |
|
7.7.6 The hydrophone positioning system |
|
|
142 | (1) |
|
7.7.7 The probe mounting system |
|
|
142 | (1) |
|
7.7.8 Calibration and accuracy |
|
|
142 | (1) |
|
7.8 The NPL ultrasound beam calibrator |
|
|
142 | (1) |
|
7.9 Measurement of acoustic power |
|
|
143 | (2) |
|
7.10 Finding worst case values |
|
|
145 | (1) |
|
7.10.1 Worst case Ispta of stationary beams, e.g. pulsed Doppler mode |
|
|
145 | (1) |
|
7.10.2 Worst case Ispta for scanned beam modes, e.g. B-mode |
|
|
146 | (1) |
|
|
146 | (3) |
|
|
147 | (2) |
|
PART 3 ULTRASOUND HYPERTHERMIA AND SURGERY |
|
|
149 | (48) |
|
8 Ultrasound Hyperthermia and the Prediction of Heating |
|
|
151 | (26) |
|
|
8.1 Ultrasound hyperthermia |
|
|
151 | (14) |
|
|
151 | (1) |
|
8.1.2 Ultrasound intensity, attenuation and absorption |
|
|
152 | (2) |
|
8.1.3 Transducers for hyperthermia |
|
|
154 | (9) |
|
8.1.4 High-intensity short-duration hyperthermia |
|
|
163 | (2) |
|
8.2 Prediction of heating |
|
|
165 | (6) |
|
|
165 | (1) |
|
8.2.2 Pennes' bioheat transfer equation |
|
|
166 | (2) |
|
8.2.3 Other approaches to thermal modelling |
|
|
168 | (3) |
|
|
171 | (6) |
|
|
172 | (1) |
|
|
172 | (5) |
|
9 Focused Ultrasound Surgery |
|
|
177 | (12) |
|
|
9.1 Mechanisms of lesion production |
|
|
178 | (1) |
|
|
178 | (1) |
|
|
179 | (1) |
|
9.2 Lesion shape and position |
|
|
179 | (1) |
|
9.3 Sources of ultrasound |
|
|
179 | (3) |
|
9.4 Imaging of focused ultrasound surgery treatments |
|
|
182 | (1) |
|
9.4.1 Ultrasound techniques |
|
|
182 | (1) |
|
9.4.2 Magnetic resonance imaging |
|
|
182 | (1) |
|
9.5 Clinical applications |
|
|
182 | (2) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
184 | (5) |
|
|
184 | (5) |
|
10 Acoustic Wave Lithotripsy |
|
|
189 | (8) |
|
|
10.1 Percutaneous continuous-wave systems |
|
|
189 | (1) |
|
10.2 Extracorporeally induced lithotripsy |
|
|
190 | (7) |
|
10.2.1 Types of pressure wave transducer |
|
|
190 | (1) |
|
10.2.2 Positioning systems |
|
|
191 | (1) |
|
|
192 | (4) |
|
|
196 | (1) |
|
PART 4 ULTRASOUND AND BUBBLES |
|
|
197 | (64) |
|
11 An Introduction to Acoustic Cavitation |
|
|
199 | (26) |
|
|
11.1 The acoustic properties of the bubble |
|
|
199 | (7) |
|
11.1.1 Stiffness and inertia |
|
|
199 | (1) |
|
|
200 | (1) |
|
11.1.3 Inertial cavitation |
|
|
201 | (5) |
|
|
206 | (4) |
|
11.3 The implications of the occurrence of one type of cavitation for the occurrence of another |
|
|
210 | (7) |
|
11.3.1 Alteration of the bubble size by rectified diffusion |
|
|
210 | (2) |
|
11.3.2 Alteration of the acoustic pressure field at the bubble by radiation forces |
|
|
212 | (2) |
|
|
214 | (1) |
|
11.3.4 Population effects |
|
|
214 | (3) |
|
11.4 The implications of the occurrence of one type of cavitation for causing change to the medium |
|
|
217 | (2) |
|
|
219 | (6) |
|
|
219 | (6) |
|
12 Echo-Enhancing (Ultrasound Contrast) Agents |
|
|
225 | (16) |
|
|
12.1 Non-bubble approaches |
|
|
225 | (1) |
|
|
226 | (10) |
|
|
226 | (3) |
|
12.2.2 Safety of contrast agents |
|
|
229 | (1) |
|
|
230 | (1) |
|
12.2.4 Clinical applications |
|
|
230 | (3) |
|
12.2.5 Quantification and functional studies |
|
|
233 | (1) |
|
12.2.6 New uses: agents and techniques |
|
|
234 | (2) |
|
|
236 | (5) |
|
|
236 | (5) |
|
13 Sonochemistry and Drug Delivery |
|
|
241 | (20) |
|
|
13.1 Cavitation and its effects |
|
|
243 | (2) |
|
13.2 What can ultrasound do for chemists? |
|
|
245 | (7) |
|
13.3 Bio-effects and drug delivery |
|
|
252 | (9) |
|
|
256 | (5) |
|
PART 5 RESEARCH TOPICS IN MEDICAL ULTRASOUND |
|
|
261 | (46) |
|
14 Imaging Elastic Properties of Tissue |
|
|
263 | (16) |
|
|
|
|
|
|
263 | (1) |
|
14.1.1 Exogenous transverse waves: imaging with MRE |
|
|
263 | (1) |
|
14.1.2 Stimulated acoustic emission: imaging with USAE |
|
|
264 | (1) |
|
14.2 Magnetic resonance elastography (MRE) |
|
|
264 | (6) |
|
|
264 | (1) |
|
|
265 | (1) |
|
|
266 | (4) |
|
14.3 Ultrasound stimulated acoustic emission (USAE) |
|
|
270 | (5) |
|
|
270 | (2) |
|
|
272 | (3) |
|
|
275 | (4) |
|
|
275 | (1) |
|
|
276 | (1) |
|
|
276 | (1) |
|
|
276 | (3) |
|
15 The Signal-to-Noise Relationship for Investigative Ultrasound |
|
|
279 | (8) |
|
|
|
286 | (1) |
|
16 Challenges in the Ultrasonic Measurement of Bone |
|
|
287 | (20) |
|
|
|
|
288 | (1) |
|
16.2 Ultrasonic measurements suitable for bone |
|
|
289 | (6) |
|
16.2.1 Speed of sound (SOS) |
|
|
291 | (1) |
|
|
292 | (3) |
|
|
295 | (1) |
|
16.3 Effect of structure on broadband ultrasonic attenuation |
|
|
295 | (2) |
|
16.4 Problems in the measurement of speed of sound |
|
|
297 | (6) |
|
16.4.1 Time domain (zero-crossing point measurement) |
|
|
297 | (3) |
|
16.4.2 Frequency domain measurements |
|
|
300 | (3) |
|
|
303 | (4) |
|
|
305 | (1) |
|
|
305 | (2) |
Index |
|
307 | |